Similarly, in patients with BLCA (TCGA, Provisional), expression of ANLN was higher in the basal than in the luminal subtypes (median expression 10.93; range 6.1–13.01 vs. median expression 9.64; range 4.87–12.25, p < 0.0001, Figure S5c) according to the mRNA clustering. Here, ANLN is linked to bladder transitional cell carcinoma.